Refludan

Refludan®

Lepirudin Hematology A recombinant hirudin for treating heparin-induced thrombocytopenia. See Heparin-induced thrombocytopenia.
References in periodicals archive ?
Lepirudin (50 mg; Refludan, Celgene Europe Ltd, Wndsor, United Kingdom) and argatroban (250 mg/2.
Angiomax, Argatroban, Refludan and Others (includes
233 billion, excluding sales related to non-core former Pharmion products, Innohep and Refludan, to be divested.
Cost of sales for 2003 included inventory charges, primarily related to Refludan, totaling $2.
Cost of sales for the first nine months of 2003 included inventory charges, primarily related to Refludan, totaling $2.
In addition to testing for Bivalirudin, the Company can also rapidly manage Melagatran, Refludan, PEG-Hirudin and Argatroban.
Cost of sales for the second quarter and the first six months of 2003 included inventory charges, primarily related to Refludan, totaling $2.
Pharmion owns the development rights for thrombosis medications, Innohep and Refludan and also purchased rights to both myelodysplastic syndrome treatment Vidaza (from Pharmacia) and blood cancer treatment thalidomide from Celegene.
Refludan is a leading treatment of thrombosis associated with the severe form of heparin-induced thrombocytopenia (HIT Type II).
The approval covers the use of the test for managing patients suffering from Heparin Induced Thrombocytopenia (HIT) who receive Refludan while undergoing cardiopulmonary bypass.
1 million for inventory write-downs and pricing adjustments relating to the Company's product Refludan, which reduced the 2003 gross margin by eight percentage points.